Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care.
暂无分享,去创建一个
C. Israel | S. Hohnloser | J. Ehrlich | Yi‐Gang Li | Carsten W Israel | Stefan H Hohnloser | G. Grönefeld | Gerian Grönefeld | Joachim R Ehrlich | Yi-Gang Li
[1] David Newman,et al. New-Onset Atrial Fibrillation : Sex Differences in Presentation, Treatment, and Outcome , 2001 .
[2] H. Crijns,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. , 2002, The New England journal of medicine.
[3] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[4] M. Brignole,et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. , 1998, Circulation.
[5] C W Israel,et al. Pace‐Termination and Pacing for Prevention of Atrial Tachyarrhythmias: Results from a Multicenter Study with an Implantable Device for Atrial Therapy , 2001, Journal of cardiovascular electrophysiology.
[6] S. Hohnloser,et al. Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomised trial , 2001 .
[7] F A Mathewson,et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.
[8] C. Israel,et al. Pacemaker systems as implantable cardiac rhythm monitors. , 2001, The American journal of cardiology.
[9] P. Defaye,et al. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study , 1998, Pacing and clinical electrophysiology : PACE.
[10] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[11] L H Kuller,et al. Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.
[12] S. Connolly,et al. Asymptomatic or “Silent” Atrial Fibrillation: Frequency in Untreated Patients and Patients Receiving Azimilide , 2003 .
[13] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[14] M A Waclawiw,et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.
[15] S. Connolly,et al. Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation. , 1996, European heart journal.
[16] V. Fuster,et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.
[17] J. McMurray,et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. , 1999, Circulation.
[18] C. Tai,et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. , 1998, Journal of the American College of Cardiology.
[19] P. Hjemdahl. Smoking, nicotine and thrombotic risk--a role for platelet dependent thrombin generation? , 2001, European heart journal.
[20] A. Camm,et al. The rhythm of the heart in active elderly subjects. , 1980, American heart journal.
[21] Amanda Neil,et al. Cardiac Event Recorders Yield More Diagnoses and Are More Cost-effective than 48-Hour Holter Monitoring in Patients with Palpitations: A Controlled Clinical Trial , 1996, Annals of Internal Medicine.
[22] M. Wijffels. The Natural History of Atrial Fibrillation: , 1999, Journal of cardiovascular electrophysiology.
[23] J. Gardin,et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.
[24] S. Hohnloser,et al. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. , 2003, European heart journal.
[25] Frédéric Costes,et al. Frequent and Prolonged Asymptomatic Episodes of Paroxysmal Atrial Fibrillation Revealed by Automatic Long‐Term Event Recorders in Patients with a Negative 24‐Hour Holter , 2002, Pacing and clinical electrophysiology : PACE.
[26] E. Pritchett,et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. , 1992, American heart journal.
[27] S. Lévy,et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. , 1999, Circulation.
[28] H. Crijns,et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .
[29] N. Sheth,et al. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators. , 2000, Circulation.